nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—CYP1A1—kidney cancer	0.269	1	CbGaD
Norfloxacin—CYP3A7—Temsirolimus—kidney cancer	0.0498	0.095	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0498	0.095	CbGbCtD
Norfloxacin—SLC22A5—Dactinomycin—kidney cancer	0.046	0.0878	CbGbCtD
Norfloxacin—CYP3A5—Temsirolimus—kidney cancer	0.0373	0.0713	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—kidney cancer	0.0336	0.0641	CbGbCtD
Norfloxacin—CYP1A1—Erlotinib—kidney cancer	0.0233	0.0445	CbGbCtD
Norfloxacin—CYP3A4—Everolimus—kidney cancer	0.0215	0.0411	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0171	0.0326	CbGbCtD
Norfloxacin—CYP3A7—Paclitaxel—kidney cancer	0.0171	0.0326	CbGbCtD
Norfloxacin—CYP3A7—Sorafenib—kidney cancer	0.0152	0.029	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.0152	0.029	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0147	0.0281	CbGbCtD
Norfloxacin—CYP3A7—Vincristine—kidney cancer	0.0147	0.0281	CbGbCtD
Norfloxacin—CYP1A2—Pazopanib—kidney cancer	0.0146	0.0279	CbGbCtD
Norfloxacin—CYP3A4—Temsirolimus—kidney cancer	0.0146	0.0278	CbGbCtD
Norfloxacin—CYP3A5—Erlotinib—kidney cancer	0.014	0.0267	CbGbCtD
Norfloxacin—CYP3A5—Paclitaxel—kidney cancer	0.0128	0.0244	CbGbCtD
Norfloxacin—CYP3A7—Sunitinib—kidney cancer	0.0123	0.0235	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.0123	0.0235	CbGbCtD
Norfloxacin—CYP3A5—Sorafenib—kidney cancer	0.0114	0.0217	CbGbCtD
Norfloxacin—CYP3A5—Vincristine—kidney cancer	0.011	0.0211	CbGbCtD
Norfloxacin—CYP1A2—Erlotinib—kidney cancer	0.0104	0.0199	CbGbCtD
Norfloxacin—CYP3A5—Sunitinib—kidney cancer	0.00922	0.0176	CbGbCtD
Norfloxacin—CYP1A2—Sorafenib—kidney cancer	0.00847	0.0162	CbGbCtD
Norfloxacin—CYP3A4—Pazopanib—kidney cancer	0.00765	0.0146	CbGbCtD
Norfloxacin—CYP3A4—Erlotinib—kidney cancer	0.00546	0.0104	CbGbCtD
Norfloxacin—CYP3A4—Paclitaxel—kidney cancer	0.00499	0.00953	CbGbCtD
Norfloxacin—CYP3A4—Sorafenib—kidney cancer	0.00444	0.00847	CbGbCtD
Norfloxacin—CYP3A4—Vinblastine—kidney cancer	0.00438	0.00836	CbGbCtD
Norfloxacin—CYP3A4—Vincristine—kidney cancer	0.00431	0.00822	CbGbCtD
Norfloxacin—CYP3A4—Sunitinib—kidney cancer	0.00359	0.00686	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—kidney cancer	0.00269	0.00514	CbGbCtD
Norfloxacin—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.00112	0.296	CbGdCrCtD
Norfloxacin—CYP1A2—urine—kidney cancer	0.00109	0.131	CbGeAlD
Norfloxacin—CYP3A4—urine—kidney cancer	0.00079	0.0945	CbGeAlD
Norfloxacin—SLC22A6—nephron tubule—kidney cancer	0.000717	0.0857	CbGeAlD
Norfloxacin—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000685	0.0819	CbGeAlD
Norfloxacin—SLC22A6—cortex of kidney—kidney cancer	0.000614	0.0734	CbGeAlD
Norfloxacin—TOP2A—Docetaxel—Paclitaxel—kidney cancer	0.000603	0.16	CbGdCrCtD
Norfloxacin—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000586	0.0701	CbGeAlD
Norfloxacin—SLC22A5—nephron tubule—kidney cancer	0.000324	0.0388	CbGeAlD
Norfloxacin—TOP2A—Vindesine—Vincristine—kidney cancer	0.000306	0.0812	CbGdCrCtD
Norfloxacin—TOP2A—Vindesine—Vinblastine—kidney cancer	0.000306	0.0812	CbGdCrCtD
Norfloxacin—SLC22A5—renal system—kidney cancer	0.000295	0.0353	CbGeAlD
Norfloxacin—TOP2A—Gefitinib—Erlotinib—kidney cancer	0.000289	0.0765	CbGdCrCtD
Norfloxacin—SLC22A5—kidney—kidney cancer	0.000285	0.0341	CbGeAlD
Norfloxacin—CYP3A5—nephron tubule—kidney cancer	0.000284	0.0339	CbGeAlD
Norfloxacin—SLC22A5—cortex of kidney—kidney cancer	0.000278	0.0332	CbGeAlD
Norfloxacin—CYP1A2—renal system—kidney cancer	0.000267	0.0319	CbGeAlD
Norfloxacin—SLC22A5—cardiac atrium—kidney cancer	0.000264	0.0316	CbGeAlD
Norfloxacin—CYP1A1—renal system—kidney cancer	0.000264	0.0315	CbGeAlD
Norfloxacin—CYP3A5—renal system—kidney cancer	0.000258	0.0308	CbGeAlD
Norfloxacin—CYP1A1—kidney—kidney cancer	0.000255	0.0305	CbGeAlD
Norfloxacin—CYP3A5—kidney—kidney cancer	0.000249	0.0298	CbGeAlD
Norfloxacin—CYP3A5—cortex of kidney—kidney cancer	0.000243	0.029	CbGeAlD
Norfloxacin—CYP1A1—cardiac atrium—kidney cancer	0.000236	0.0282	CbGeAlD
Norfloxacin—TOP2A—Vinorelbine—Vincristine—kidney cancer	0.000193	0.0513	CbGdCrCtD
Norfloxacin—TOP2A—Vinorelbine—Vinblastine—kidney cancer	0.000193	0.0513	CbGdCrCtD
Norfloxacin—CYP3A4—renal system—kidney cancer	0.000193	0.0231	CbGeAlD
Norfloxacin—CYP3A4—kidney—kidney cancer	0.000187	0.0224	CbGeAlD
Norfloxacin—TOP2A—Vincristine—Vinblastine—kidney cancer	0.000165	0.0438	CbGdCrCtD
Norfloxacin—TOP2A—Vinblastine—Vincristine—kidney cancer	0.000133	0.0352	CbGdCrCtD
Norfloxacin—TOP2A—Cytarabine—Gemcitabine—kidney cancer	0.000109	0.0288	CbGdCrCtD
Norfloxacin—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000104	0.000645	CcSEcCtD
Norfloxacin—Hypoaesthesia—Capecitabine—kidney cancer	0.000104	0.000643	CcSEcCtD
Norfloxacin—Tremor—Paclitaxel—kidney cancer	0.000103	0.000642	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000103	0.000642	CcSEcCtD
Norfloxacin—Dermatitis exfoliative—Doxorubicin—kidney cancer	0.000103	0.000638	CcSEcCtD
Norfloxacin—Hypersensitivity—Sorafenib—kidney cancer	0.000103	0.000638	CcSEcCtD
Norfloxacin—Insomnia—Vincristine—kidney cancer	0.000103	0.000637	CcSEcCtD
Norfloxacin—Anorexia—Gemcitabine—kidney cancer	0.000103	0.000637	CcSEcCtD
Norfloxacin—Vomiting—Vinblastine—kidney cancer	0.000103	0.000636	CcSEcCtD
Norfloxacin—Dizziness—Erlotinib—kidney cancer	0.000102	0.000636	CcSEcCtD
Norfloxacin—Vomiting—Everolimus—kidney cancer	0.000102	0.000634	CcSEcCtD
Norfloxacin—Paraesthesia—Vincristine—kidney cancer	0.000102	0.000632	CcSEcCtD
Norfloxacin—Dermatitis bullous—Doxorubicin—kidney cancer	0.000102	0.00063	CcSEcCtD
Norfloxacin—Agitation—Paclitaxel—kidney cancer	0.000101	0.00063	CcSEcCtD
Norfloxacin—Rash—Everolimus—kidney cancer	0.000101	0.000629	CcSEcCtD
Norfloxacin—Dermatitis—Everolimus—kidney cancer	0.000101	0.000628	CcSEcCtD
Norfloxacin—Headache—Vinblastine—kidney cancer	0.000101	0.000627	CcSEcCtD
Norfloxacin—Angioedema—Paclitaxel—kidney cancer	0.000101	0.000626	CcSEcCtD
Norfloxacin—Headache—Everolimus—kidney cancer	0.000101	0.000625	CcSEcCtD
Norfloxacin—Body temperature increased—Dactinomycin—kidney cancer	0.0001	0.000623	CcSEcCtD
Norfloxacin—Abdominal pain—Dactinomycin—kidney cancer	0.0001	0.000623	CcSEcCtD
Norfloxacin—Visual impairment—Capecitabine—kidney cancer	0.0001	0.000623	CcSEcCtD
Norfloxacin—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.0001	0.000622	CcSEcCtD
Norfloxacin—Asthenia—Sorafenib—kidney cancer	0.0001	0.000621	CcSEcCtD
Norfloxacin—Hypoglycaemia—Doxorubicin—kidney cancer	9.94e-05	0.000617	CcSEcCtD
Norfloxacin—Vertigo—Paclitaxel—kidney cancer	9.92e-05	0.000616	CcSEcCtD
Norfloxacin—Leukopenia—Paclitaxel—kidney cancer	9.89e-05	0.000614	CcSEcCtD
Norfloxacin—Hypersensitivity—Sunitinib—kidney cancer	9.88e-05	0.000613	CcSEcCtD
Norfloxacin—Decreased appetite—Vincristine—kidney cancer	9.86e-05	0.000612	CcSEcCtD
Norfloxacin—Pruritus—Sorafenib—kidney cancer	9.86e-05	0.000612	CcSEcCtD
Norfloxacin—Vomiting—Erlotinib—kidney cancer	9.85e-05	0.000612	CcSEcCtD
Norfloxacin—Erythema multiforme—Capecitabine—kidney cancer	9.84e-05	0.000611	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	9.81e-05	0.000609	CcSEcCtD
Norfloxacin—Fatigue—Vincristine—kidney cancer	9.78e-05	0.000607	CcSEcCtD
Norfloxacin—Rash—Erlotinib—kidney cancer	9.77e-05	0.000606	CcSEcCtD
Norfloxacin—Dermatitis—Erlotinib—kidney cancer	9.76e-05	0.000606	CcSEcCtD
Norfloxacin—Palpitations—Paclitaxel—kidney cancer	9.76e-05	0.000606	CcSEcCtD
Norfloxacin—Insomnia—Gemcitabine—kidney cancer	9.74e-05	0.000604	CcSEcCtD
Norfloxacin—Headache—Erlotinib—kidney cancer	9.71e-05	0.000603	CcSEcCtD
Norfloxacin—Tinnitus—Capecitabine—kidney cancer	9.71e-05	0.000602	CcSEcCtD
Norfloxacin—Constipation—Vincristine—kidney cancer	9.7e-05	0.000602	CcSEcCtD
Norfloxacin—Diplopia—Doxorubicin—kidney cancer	9.7e-05	0.000602	CcSEcCtD
Norfloxacin—Osteoarthritis—Doxorubicin—kidney cancer	9.7e-05	0.000602	CcSEcCtD
Norfloxacin—Paraesthesia—Gemcitabine—kidney cancer	9.67e-05	0.0006	CcSEcCtD
Norfloxacin—Asthenia—Sunitinib—kidney cancer	9.63e-05	0.000597	CcSEcCtD
Norfloxacin—Dyspnoea—Gemcitabine—kidney cancer	9.6e-05	0.000596	CcSEcCtD
Norfloxacin—Nausea—Vinblastine—kidney cancer	9.58e-05	0.000594	CcSEcCtD
Norfloxacin—Somnolence—Gemcitabine—kidney cancer	9.57e-05	0.000594	CcSEcCtD
Norfloxacin—Convulsion—Paclitaxel—kidney cancer	9.57e-05	0.000594	CcSEcCtD
Norfloxacin—Nausea—Everolimus—kidney cancer	9.54e-05	0.000592	CcSEcCtD
Norfloxacin—Diarrhoea—Sorafenib—kidney cancer	9.54e-05	0.000592	CcSEcCtD
Norfloxacin—Pruritus—Sunitinib—kidney cancer	9.49e-05	0.000589	CcSEcCtD
Norfloxacin—Chest pain—Paclitaxel—kidney cancer	9.4e-05	0.000584	CcSEcCtD
Norfloxacin—Arthralgia—Paclitaxel—kidney cancer	9.4e-05	0.000584	CcSEcCtD
Norfloxacin—Myalgia—Paclitaxel—kidney cancer	9.4e-05	0.000584	CcSEcCtD
Norfloxacin—Anxiety—Paclitaxel—kidney cancer	9.37e-05	0.000581	CcSEcCtD
Norfloxacin—Decreased appetite—Gemcitabine—kidney cancer	9.36e-05	0.000581	CcSEcCtD
Norfloxacin—Hypersensitivity—Dactinomycin—kidney cancer	9.36e-05	0.000581	CcSEcCtD
Norfloxacin—Chills—Capecitabine—kidney cancer	9.34e-05	0.00058	CcSEcCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—kidney cancer	9.33e-05	0.0247	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—kidney cancer	9.33e-05	0.0247	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—kidney cancer	9.33e-05	0.0247	CbGdCrCtD
Norfloxacin—Fatigue—Gemcitabine—kidney cancer	9.28e-05	0.000576	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Vincristine—kidney cancer	9.28e-05	0.000576	CcSEcCtD
Norfloxacin—Dizziness—Sorafenib—kidney cancer	9.22e-05	0.000572	CcSEcCtD
Norfloxacin—Constipation—Gemcitabine—kidney cancer	9.21e-05	0.000571	CcSEcCtD
Norfloxacin—Nausea—Erlotinib—kidney cancer	9.21e-05	0.000571	CcSEcCtD
Norfloxacin—Dry mouth—Paclitaxel—kidney cancer	9.2e-05	0.000571	CcSEcCtD
Norfloxacin—Diarrhoea—Sunitinib—kidney cancer	9.18e-05	0.00057	CcSEcCtD
Norfloxacin—Ataxia—Doxorubicin—kidney cancer	9.12e-05	0.000566	CcSEcCtD
Norfloxacin—Asthenia—Dactinomycin—kidney cancer	9.11e-05	0.000566	CcSEcCtD
Norfloxacin—Confusional state—Paclitaxel—kidney cancer	9.09e-05	0.000564	CcSEcCtD
Norfloxacin—Blood creatinine increased—Doxorubicin—kidney cancer	9.09e-05	0.000564	CcSEcCtD
Norfloxacin—Erythema—Capecitabine—kidney cancer	9.06e-05	0.000562	CcSEcCtD
Norfloxacin—Anaphylactic shock—Paclitaxel—kidney cancer	9.01e-05	0.000559	CcSEcCtD
Norfloxacin—Oedema—Paclitaxel—kidney cancer	9.01e-05	0.000559	CcSEcCtD
Norfloxacin—Body temperature increased—Vincristine—kidney cancer	8.97e-05	0.000557	CcSEcCtD
Norfloxacin—Abdominal pain—Vincristine—kidney cancer	8.97e-05	0.000557	CcSEcCtD
Norfloxacin—Liver function test abnormal—Doxorubicin—kidney cancer	8.96e-05	0.000556	CcSEcCtD
Norfloxacin—Flatulence—Capecitabine—kidney cancer	8.93e-05	0.000554	CcSEcCtD
Norfloxacin—Dysgeusia—Capecitabine—kidney cancer	8.88e-05	0.000551	CcSEcCtD
Norfloxacin—Dizziness—Sunitinib—kidney cancer	8.87e-05	0.000551	CcSEcCtD
Norfloxacin—Feeling abnormal—Gemcitabine—kidney cancer	8.87e-05	0.000551	CcSEcCtD
Norfloxacin—Vomiting—Sorafenib—kidney cancer	8.87e-05	0.00055	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—kidney cancer	8.86e-05	0.00055	CcSEcCtD
Norfloxacin—Thrombocytopenia—Paclitaxel—kidney cancer	8.82e-05	0.000548	CcSEcCtD
Norfloxacin—Rash—Sorafenib—kidney cancer	8.79e-05	0.000546	CcSEcCtD
Norfloxacin—Dermatitis—Sorafenib—kidney cancer	8.78e-05	0.000545	CcSEcCtD
Norfloxacin—Back pain—Capecitabine—kidney cancer	8.77e-05	0.000544	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	8.74e-05	0.000542	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	8.74e-05	0.000542	CcSEcCtD
Norfloxacin—Headache—Sorafenib—kidney cancer	8.73e-05	0.000542	CcSEcCtD
Norfloxacin—Muscle spasms—Capecitabine—kidney cancer	8.71e-05	0.000541	CcSEcCtD
Norfloxacin—Hyperhidrosis—Paclitaxel—kidney cancer	8.71e-05	0.000541	CcSEcCtD
Norfloxacin—Diarrhoea—Dactinomycin—kidney cancer	8.69e-05	0.000539	CcSEcCtD
Norfloxacin—Anorexia—Paclitaxel—kidney cancer	8.59e-05	0.000533	CcSEcCtD
Norfloxacin—Vision blurred—Capecitabine—kidney cancer	8.54e-05	0.00053	CcSEcCtD
Norfloxacin—Vomiting—Sunitinib—kidney cancer	8.53e-05	0.000529	CcSEcCtD
Norfloxacin—Body temperature increased—Gemcitabine—kidney cancer	8.51e-05	0.000528	CcSEcCtD
Norfloxacin—Tremor—Capecitabine—kidney cancer	8.49e-05	0.000527	CcSEcCtD
Norfloxacin—Rash—Sunitinib—kidney cancer	8.46e-05	0.000525	CcSEcCtD
Norfloxacin—Dermatitis—Sunitinib—kidney cancer	8.45e-05	0.000525	CcSEcCtD
Norfloxacin—Headache—Sunitinib—kidney cancer	8.41e-05	0.000522	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—kidney cancer	8.38e-05	0.00052	CcSEcCtD
Norfloxacin—Hypersensitivity—Vincristine—kidney cancer	8.36e-05	0.000519	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—kidney cancer	8.3e-05	0.000515	CcSEcCtD
Norfloxacin—Nausea—Sorafenib—kidney cancer	8.28e-05	0.000514	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—kidney cancer	8.22e-05	0.00051	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	8.21e-05	0.00051	CcSEcCtD
Norfloxacin—Insomnia—Paclitaxel—kidney cancer	8.15e-05	0.000506	CcSEcCtD
Norfloxacin—Vertigo—Capecitabine—kidney cancer	8.14e-05	0.000505	CcSEcCtD
Norfloxacin—Asthenia—Vincristine—kidney cancer	8.14e-05	0.000505	CcSEcCtD
Norfloxacin—Leukopenia—Capecitabine—kidney cancer	8.11e-05	0.000503	CcSEcCtD
Norfloxacin—Paraesthesia—Paclitaxel—kidney cancer	8.09e-05	0.000502	CcSEcCtD
Norfloxacin—Vomiting—Dactinomycin—kidney cancer	8.08e-05	0.000501	CcSEcCtD
Norfloxacin—Dyspnoea—Paclitaxel—kidney cancer	8.04e-05	0.000499	CcSEcCtD
Norfloxacin—Somnolence—Paclitaxel—kidney cancer	8.01e-05	0.000497	CcSEcCtD
Norfloxacin—Palpitations—Capecitabine—kidney cancer	8.01e-05	0.000497	CcSEcCtD
Norfloxacin—Rash—Dactinomycin—kidney cancer	8.01e-05	0.000497	CcSEcCtD
Norfloxacin—Nausea—Sunitinib—kidney cancer	7.97e-05	0.000495	CcSEcCtD
Norfloxacin—Dyspepsia—Paclitaxel—kidney cancer	7.93e-05	0.000492	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—kidney cancer	7.84e-05	0.000487	CcSEcCtD
Norfloxacin—Decreased appetite—Paclitaxel—kidney cancer	7.84e-05	0.000486	CcSEcCtD
Norfloxacin—TOP2A—Azacitidine—Gemcitabine—kidney cancer	7.79e-05	0.0207	CbGdCrCtD
Norfloxacin—Fatigue—Paclitaxel—kidney cancer	7.77e-05	0.000482	CcSEcCtD
Norfloxacin—Diarrhoea—Vincristine—kidney cancer	7.76e-05	0.000482	CcSEcCtD
Norfloxacin—Asthenia—Gemcitabine—kidney cancer	7.72e-05	0.000479	CcSEcCtD
Norfloxacin—Myalgia—Capecitabine—kidney cancer	7.72e-05	0.000479	CcSEcCtD
Norfloxacin—Arthralgia—Capecitabine—kidney cancer	7.72e-05	0.000479	CcSEcCtD
Norfloxacin—Chest pain—Capecitabine—kidney cancer	7.72e-05	0.000479	CcSEcCtD
Norfloxacin—Constipation—Paclitaxel—kidney cancer	7.71e-05	0.000478	CcSEcCtD
Norfloxacin—Anxiety—Capecitabine—kidney cancer	7.69e-05	0.000477	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—kidney cancer	7.65e-05	0.000475	CcSEcCtD
Norfloxacin—Pruritus—Gemcitabine—kidney cancer	7.62e-05	0.000473	CcSEcCtD
Norfloxacin—Dry mouth—Capecitabine—kidney cancer	7.55e-05	0.000468	CcSEcCtD
Norfloxacin—Nausea—Dactinomycin—kidney cancer	7.54e-05	0.000468	CcSEcCtD
Norfloxacin—Dizziness—Vincristine—kidney cancer	7.5e-05	0.000466	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—kidney cancer	7.48e-05	0.000464	CcSEcCtD
Norfloxacin—Confusional state—Capecitabine—kidney cancer	7.46e-05	0.000463	CcSEcCtD
Norfloxacin—Feeling abnormal—Paclitaxel—kidney cancer	7.43e-05	0.000461	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	7.41e-05	0.00046	CcSEcCtD
Norfloxacin—Oedema—Capecitabine—kidney cancer	7.4e-05	0.000459	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Paclitaxel—kidney cancer	7.37e-05	0.000457	CcSEcCtD
Norfloxacin—Diarrhoea—Gemcitabine—kidney cancer	7.37e-05	0.000457	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—kidney cancer	7.35e-05	0.000456	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—kidney cancer	7.33e-05	0.000455	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—kidney cancer	7.29e-05	0.000452	CcSEcCtD
Norfloxacin—Stomatitis—Doxorubicin—kidney cancer	7.29e-05	0.000452	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—kidney cancer	7.27e-05	0.000451	CcSEcCtD
Norfloxacin—Thrombocytopenia—Capecitabine—kidney cancer	7.24e-05	0.000449	CcSEcCtD
Norfloxacin—Vomiting—Vincristine—kidney cancer	7.22e-05	0.000448	CcSEcCtD
Norfloxacin—Urticaria—Paclitaxel—kidney cancer	7.16e-05	0.000444	CcSEcCtD
Norfloxacin—Rash—Vincristine—kidney cancer	7.16e-05	0.000444	CcSEcCtD
Norfloxacin—Hyperhidrosis—Capecitabine—kidney cancer	7.15e-05	0.000444	CcSEcCtD
Norfloxacin—Dermatitis—Vincristine—kidney cancer	7.15e-05	0.000444	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—kidney cancer	7.13e-05	0.000442	CcSEcCtD
Norfloxacin—Abdominal pain—Paclitaxel—kidney cancer	7.13e-05	0.000442	CcSEcCtD
Norfloxacin—Body temperature increased—Paclitaxel—kidney cancer	7.13e-05	0.000442	CcSEcCtD
Norfloxacin—Headache—Vincristine—kidney cancer	7.11e-05	0.000441	CcSEcCtD
Norfloxacin—Anorexia—Capecitabine—kidney cancer	7.05e-05	0.000438	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—kidney cancer	6.98e-05	0.000433	CcSEcCtD
Norfloxacin—Vomiting—Gemcitabine—kidney cancer	6.84e-05	0.000425	CcSEcCtD
Norfloxacin—Rash—Gemcitabine—kidney cancer	6.79e-05	0.000421	CcSEcCtD
Norfloxacin—Dermatitis—Gemcitabine—kidney cancer	6.78e-05	0.000421	CcSEcCtD
Norfloxacin—Headache—Gemcitabine—kidney cancer	6.74e-05	0.000419	CcSEcCtD
Norfloxacin—Nausea—Vincristine—kidney cancer	6.74e-05	0.000418	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.74e-05	0.000418	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—kidney cancer	6.71e-05	0.000416	CcSEcCtD
Norfloxacin—Insomnia—Capecitabine—kidney cancer	6.69e-05	0.000415	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—kidney cancer	6.68e-05	0.000414	CcSEcCtD
Norfloxacin—Paraesthesia—Capecitabine—kidney cancer	6.64e-05	0.000412	CcSEcCtD
Norfloxacin—Hypersensitivity—Paclitaxel—kidney cancer	6.64e-05	0.000412	CcSEcCtD
Norfloxacin—Dyspnoea—Capecitabine—kidney cancer	6.59e-05	0.000409	CcSEcCtD
Norfloxacin—Dyspepsia—Capecitabine—kidney cancer	6.51e-05	0.000404	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—kidney cancer	6.47e-05	0.000401	CcSEcCtD
Norfloxacin—Asthenia—Paclitaxel—kidney cancer	6.47e-05	0.000401	CcSEcCtD
Norfloxacin—Decreased appetite—Capecitabine—kidney cancer	6.43e-05	0.000399	CcSEcCtD
Norfloxacin—Nausea—Gemcitabine—kidney cancer	6.39e-05	0.000397	CcSEcCtD
Norfloxacin—Fatigue—Capecitabine—kidney cancer	6.38e-05	0.000396	CcSEcCtD
Norfloxacin—Pruritus—Paclitaxel—kidney cancer	6.38e-05	0.000396	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—kidney cancer	6.35e-05	0.000394	CcSEcCtD
Norfloxacin—Constipation—Capecitabine—kidney cancer	6.33e-05	0.000393	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—kidney cancer	6.26e-05	0.000388	CcSEcCtD
Norfloxacin—Diarrhoea—Paclitaxel—kidney cancer	6.17e-05	0.000383	CcSEcCtD
Norfloxacin—Feeling abnormal—Capecitabine—kidney cancer	6.1e-05	0.000378	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Capecitabine—kidney cancer	6.05e-05	0.000375	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—kidney cancer	6.02e-05	0.000374	CcSEcCtD
Norfloxacin—Dizziness—Paclitaxel—kidney cancer	5.96e-05	0.00037	CcSEcCtD
Norfloxacin—Urticaria—Capecitabine—kidney cancer	5.88e-05	0.000365	CcSEcCtD
Norfloxacin—Abdominal pain—Capecitabine—kidney cancer	5.85e-05	0.000363	CcSEcCtD
Norfloxacin—Body temperature increased—Capecitabine—kidney cancer	5.85e-05	0.000363	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—kidney cancer	5.84e-05	0.000363	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—kidney cancer	5.76e-05	0.000357	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—kidney cancer	5.73e-05	0.000356	CcSEcCtD
Norfloxacin—Vomiting—Paclitaxel—kidney cancer	5.73e-05	0.000356	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—kidney cancer	5.72e-05	0.000355	CcSEcCtD
Norfloxacin—Rash—Paclitaxel—kidney cancer	5.68e-05	0.000353	CcSEcCtD
Norfloxacin—Dermatitis—Paclitaxel—kidney cancer	5.68e-05	0.000352	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—kidney cancer	5.67e-05	0.000352	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—kidney cancer	5.65e-05	0.000351	CcSEcCtD
Norfloxacin—Headache—Paclitaxel—kidney cancer	5.65e-05	0.00035	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—kidney cancer	5.62e-05	0.000349	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—kidney cancer	5.51e-05	0.000342	CcSEcCtD
Norfloxacin—Hypersensitivity—Capecitabine—kidney cancer	5.45e-05	0.000338	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—kidney cancer	5.37e-05	0.000333	CcSEcCtD
Norfloxacin—Nausea—Paclitaxel—kidney cancer	5.35e-05	0.000332	CcSEcCtD
Norfloxacin—Asthenia—Capecitabine—kidney cancer	5.31e-05	0.000329	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—kidney cancer	5.25e-05	0.000326	CcSEcCtD
Norfloxacin—Pruritus—Capecitabine—kidney cancer	5.23e-05	0.000325	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—kidney cancer	5.23e-05	0.000325	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—kidney cancer	5.16e-05	0.00032	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—kidney cancer	5.06e-05	0.000314	CcSEcCtD
Norfloxacin—Diarrhoea—Capecitabine—kidney cancer	5.06e-05	0.000314	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—kidney cancer	4.97e-05	0.000309	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—kidney cancer	4.97e-05	0.000309	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—kidney cancer	4.97e-05	0.000309	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—kidney cancer	4.96e-05	0.000308	CcSEcCtD
Norfloxacin—Dizziness—Capecitabine—kidney cancer	4.89e-05	0.000304	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—kidney cancer	4.86e-05	0.000302	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—kidney cancer	4.81e-05	0.000298	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—kidney cancer	4.77e-05	0.000296	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—kidney cancer	4.77e-05	0.000296	CcSEcCtD
Norfloxacin—Vomiting—Capecitabine—kidney cancer	4.7e-05	0.000292	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—kidney cancer	4.67e-05	0.00029	CcSEcCtD
Norfloxacin—Rash—Capecitabine—kidney cancer	4.66e-05	0.000289	CcSEcCtD
Norfloxacin—Dermatitis—Capecitabine—kidney cancer	4.66e-05	0.000289	CcSEcCtD
Norfloxacin—Headache—Capecitabine—kidney cancer	4.63e-05	0.000288	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—kidney cancer	4.61e-05	0.000286	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—kidney cancer	4.54e-05	0.000282	CcSEcCtD
Norfloxacin—Nausea—Capecitabine—kidney cancer	4.39e-05	0.000273	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.34e-05	0.00027	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—kidney cancer	4.31e-05	0.000268	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—kidney cancer	4.28e-05	0.000266	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—kidney cancer	4.25e-05	0.000264	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—kidney cancer	4.24e-05	0.000263	CcSEcCtD
Norfloxacin—Dyspepsia—Doxorubicin—kidney cancer	4.2e-05	0.00026	CcSEcCtD
Norfloxacin—Decreased appetite—Doxorubicin—kidney cancer	4.14e-05	0.000257	CcSEcCtD
Norfloxacin—Fatigue—Doxorubicin—kidney cancer	4.11e-05	0.000255	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—kidney cancer	4.08e-05	0.000253	CcSEcCtD
Norfloxacin—Feeling abnormal—Doxorubicin—kidney cancer	3.93e-05	0.000244	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—kidney cancer	3.9e-05	0.000242	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—kidney cancer	3.79e-05	0.000235	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—kidney cancer	3.77e-05	0.000234	CcSEcCtD
Norfloxacin—Body temperature increased—Doxorubicin—kidney cancer	3.77e-05	0.000234	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—kidney cancer	3.51e-05	0.000218	CcSEcCtD
Norfloxacin—Asthenia—Doxorubicin—kidney cancer	3.42e-05	0.000212	CcSEcCtD
Norfloxacin—Pruritus—Doxorubicin—kidney cancer	3.37e-05	0.000209	CcSEcCtD
Norfloxacin—Diarrhoea—Doxorubicin—kidney cancer	3.26e-05	0.000202	CcSEcCtD
Norfloxacin—Dizziness—Doxorubicin—kidney cancer	3.15e-05	0.000196	CcSEcCtD
Norfloxacin—Vomiting—Doxorubicin—kidney cancer	3.03e-05	0.000188	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—kidney cancer	3.01e-05	0.000187	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—kidney cancer	3e-05	0.000186	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—kidney cancer	2.99e-05	0.000185	CcSEcCtD
Norfloxacin—Nausea—Doxorubicin—kidney cancer	2.83e-05	0.000176	CcSEcCtD
Norfloxacin—CYP2A6—Metabolism—GLIPR1—kidney cancer	2.44e-05	0.000727	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.43e-05	0.000725	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.43e-05	0.000724	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PDHB—kidney cancer	2.36e-05	0.000703	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.35e-05	0.000701	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	2.35e-05	0.000701	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—POMC—kidney cancer	2.35e-05	0.000701	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GPC3—kidney cancer	2.32e-05	0.000693	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	2.3e-05	0.000686	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.27e-05	0.000678	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—APRT—kidney cancer	2.27e-05	0.000676	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—FH—kidney cancer	2.27e-05	0.000676	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA2—kidney cancer	2.26e-05	0.000674	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—kidney cancer	2.26e-05	0.000673	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.23e-05	0.000666	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PDHB—kidney cancer	2.23e-05	0.000664	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—POMC—kidney cancer	2.22e-05	0.000662	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CCBL1—kidney cancer	2.22e-05	0.000661	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALAD—kidney cancer	2.2e-05	0.000657	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTP1—kidney cancer	2.18e-05	0.00065	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	2.17e-05	0.000648	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ST3GAL2—kidney cancer	2.15e-05	0.000641	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	2.15e-05	0.000641	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GPC3—kidney cancer	2.13e-05	0.000635	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ALDH1A1—kidney cancer	2.1e-05	0.000627	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CCBL1—kidney cancer	2.09e-05	0.000625	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA2—kidney cancer	2.07e-05	0.000618	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.07e-05	0.000618	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.06e-05	0.000614	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—kidney cancer	2.05e-05	0.00061	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALAD—kidney cancer	2.02e-05	0.000602	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PGK1—kidney cancer	2.02e-05	0.000601	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC5A3—kidney cancer	2.02e-05	0.000601	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—GSTM1—kidney cancer	2e-05	0.000598	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—LDHB—kidney cancer	1.98e-05	0.000589	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	1.98e-05	0.000589	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ST3GAL2—kidney cancer	1.97e-05	0.000588	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ALDH1A1—kidney cancer	1.93e-05	0.000575	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPAT—kidney cancer	1.92e-05	0.000573	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GLIPR1—kidney cancer	1.92e-05	0.000573	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	1.9e-05	0.000566	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.89e-05	0.000565	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	1.87e-05	0.000559	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PGK1—kidney cancer	1.85e-05	0.000551	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC5A3—kidney cancer	1.85e-05	0.000551	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2A—kidney cancer	1.83e-05	0.000546	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPAT—kidney cancer	1.82e-05	0.000542	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GLIPR1—kidney cancer	1.82e-05	0.000542	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.81e-05	0.00054	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—LDHB—kidney cancer	1.81e-05	0.00054	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.79e-05	0.000535	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—FH—kidney cancer	1.79e-05	0.000533	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—APRT—kidney cancer	1.79e-05	0.000533	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.78e-05	0.000529	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—kidney cancer	1.73e-05	0.000515	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CA9—kidney cancer	1.71e-05	0.000511	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—FH—kidney cancer	1.69e-05	0.000504	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—APRT—kidney cancer	1.69e-05	0.000504	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.68e-05	0.000502	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GPC3—kidney cancer	1.68e-05	0.000501	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ACY1—kidney cancer	1.67e-05	0.000498	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.66e-05	0.000495	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.65e-05	0.000492	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA2—kidney cancer	1.63e-05	0.000488	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1B—kidney cancer	1.62e-05	0.000483	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALAD—kidney cancer	1.59e-05	0.000475	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GPC3—kidney cancer	1.59e-05	0.000473	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CA9—kidney cancer	1.57e-05	0.000468	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ST3GAL2—kidney cancer	1.55e-05	0.000464	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—kidney cancer	1.55e-05	0.000463	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.55e-05	0.000461	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—kidney cancer	1.55e-05	0.000461	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA2—kidney cancer	1.54e-05	0.000461	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.53e-05	0.000455	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ALDH1A1—kidney cancer	1.52e-05	0.000453	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALAD—kidney cancer	1.5e-05	0.000449	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ST3GAL2—kidney cancer	1.47e-05	0.000438	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.47e-05	0.000437	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CRABP1—kidney cancer	1.46e-05	0.000435	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PGK1—kidney cancer	1.46e-05	0.000435	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC5A3—kidney cancer	1.46e-05	0.000435	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.45e-05	0.000431	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ALDH1A1—kidney cancer	1.44e-05	0.000428	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—LDHB—kidney cancer	1.43e-05	0.000426	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.43e-05	0.000425	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	1.42e-05	0.000425	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PDHB—kidney cancer	1.42e-05	0.000424	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—POMC—kidney cancer	1.42e-05	0.000422	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—kidney cancer	1.39e-05	0.000413	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC5A3—kidney cancer	1.38e-05	0.000411	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PGK1—kidney cancer	1.38e-05	0.000411	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—kidney cancer	1.36e-05	0.000405	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ITPR2—kidney cancer	1.35e-05	0.000404	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—LDHB—kidney cancer	1.35e-05	0.000403	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CRABP1—kidney cancer	1.34e-05	0.000398	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CCBL1—kidney cancer	1.34e-05	0.000398	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ACY1—kidney cancer	1.29e-05	0.000385	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MAPK3—kidney cancer	1.27e-05	0.00038	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ITPR2—kidney cancer	1.24e-05	0.00037	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—kidney cancer	1.24e-05	0.00037	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CA9—kidney cancer	1.24e-05	0.000369	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTT1—kidney cancer	1.24e-05	0.000368	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ACHE—kidney cancer	1.24e-05	0.000368	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MAPK1—kidney cancer	1.21e-05	0.000362	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.21e-05	0.00036	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	1.17e-05	0.00035	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CA9—kidney cancer	1.17e-05	0.000349	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SCARB1—kidney cancer	1.17e-05	0.000349	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.16e-05	0.000345	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPAT—kidney cancer	1.16e-05	0.000345	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS1—kidney cancer	1.16e-05	0.000345	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.14e-05	0.000341	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PSMD7—kidney cancer	1.14e-05	0.000339	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTT1—kidney cancer	1.13e-05	0.000338	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ACHE—kidney cancer	1.13e-05	0.000338	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.13e-05	0.000338	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PDHB—kidney cancer	1.1e-05	0.000327	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—POMC—kidney cancer	1.09e-05	0.000326	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—APRT—kidney cancer	1.08e-05	0.000321	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—FH—kidney cancer	1.08e-05	0.000321	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—BCHE—kidney cancer	1.08e-05	0.000321	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SCARB1—kidney cancer	1.07e-05	0.00032	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC5A5—kidney cancer	1.06e-05	0.000317	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS1—kidney cancer	1.06e-05	0.000316	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CRABP1—kidney cancer	1.05e-05	0.000314	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.05e-05	0.000314	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PSMD7—kidney cancer	1.04e-05	0.00031	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CCBL1—kidney cancer	1.03e-05	0.000307	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC2A1—kidney cancer	1.03e-05	0.000306	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—kidney cancer	1.02e-05	0.000304	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GPC3—kidney cancer	1.01e-05	0.000302	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CRABP1—kidney cancer	9.95e-06	0.000297	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—BCHE—kidney cancer	9.86e-06	0.000294	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA2—kidney cancer	9.85e-06	0.000294	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ITPR2—kidney cancer	9.79e-06	0.000292	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC5A5—kidney cancer	9.74e-06	0.000291	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALAD—kidney cancer	9.6e-06	0.000286	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC2A1—kidney cancer	9.41e-06	0.000281	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ST3GAL2—kidney cancer	9.37e-06	0.000279	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ITPR2—kidney cancer	9.25e-06	0.000276	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ALDH1A1—kidney cancer	9.15e-06	0.000273	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GLIPR1—kidney cancer	8.94e-06	0.000267	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPAT—kidney cancer	8.94e-06	0.000267	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTT1—kidney cancer	8.93e-06	0.000266	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ACHE—kidney cancer	8.93e-06	0.000266	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PGK1—kidney cancer	8.78e-06	0.000262	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC5A3—kidney cancer	8.78e-06	0.000262	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—LDHB—kidney cancer	8.61e-06	0.000257	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTP1—kidney cancer	8.56e-06	0.000255	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.53e-06	0.000254	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SCARB1—kidney cancer	8.45e-06	0.000252	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ACHE—kidney cancer	8.44e-06	0.000252	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTT1—kidney cancer	8.44e-06	0.000252	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS1—kidney cancer	8.37e-06	0.00025	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—FH—kidney cancer	8.31e-06	0.000248	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—APRT—kidney cancer	8.31e-06	0.000248	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PSMD7—kidney cancer	8.21e-06	0.000245	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCB1—kidney cancer	8.11e-06	0.000242	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SCARB1—kidney cancer	7.99e-06	0.000238	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS1—kidney cancer	7.91e-06	0.000236	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—GSTM1—kidney cancer	7.87e-06	0.000235	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTP1—kidney cancer	7.85e-06	0.000234	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GPC3—kidney cancer	7.81e-06	0.000233	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—BCHE—kidney cancer	7.78e-06	0.000232	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PSMD7—kidney cancer	7.75e-06	0.000231	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC5A5—kidney cancer	7.68e-06	0.000229	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA2—kidney cancer	7.6e-06	0.000227	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CA9—kidney cancer	7.46e-06	0.000223	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP1A1—kidney cancer	7.46e-06	0.000222	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCB1—kidney cancer	7.43e-06	0.000222	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC2A1—kidney cancer	7.42e-06	0.000221	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALAD—kidney cancer	7.41e-06	0.000221	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—BCHE—kidney cancer	7.35e-06	0.000219	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.29e-06	0.000218	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC5A5—kidney cancer	7.26e-06	0.000217	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.23e-06	0.000216	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—GSTM1—kidney cancer	7.21e-06	0.000215	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.06e-06	0.000211	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC2A1—kidney cancer	7.01e-06	0.000209	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP1A1—kidney cancer	6.84e-06	0.000204	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.8e-06	0.000203	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PGK1—kidney cancer	6.77e-06	0.000202	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC5A3—kidney cancer	6.77e-06	0.000202	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—LDHB—kidney cancer	6.64e-06	0.000198	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CRABP1—kidney cancer	6.35e-06	0.000189	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTP1—kidney cancer	6.19e-06	0.000185	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.93e-06	0.000177	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ITPR2—kidney cancer	5.9e-06	0.000176	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCB1—kidney cancer	5.86e-06	0.000175	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTP1—kidney cancer	5.85e-06	0.000174	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CA9—kidney cancer	5.76e-06	0.000172	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—GSTM1—kidney cancer	5.69e-06	0.00017	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—POMC—kidney cancer	5.56e-06	0.000166	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCB1—kidney cancer	5.54e-06	0.000165	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.44e-06	0.000162	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1A1—kidney cancer	5.39e-06	0.000161	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ACHE—kidney cancer	5.38e-06	0.00016	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTT1—kidney cancer	5.38e-06	0.00016	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—GSTM1—kidney cancer	5.37e-06	0.00016	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—POMC—kidney cancer	5.1e-06	0.000152	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SCARB1—kidney cancer	5.09e-06	0.000152	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS1—kidney cancer	5.04e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PSMD7—kidney cancer	4.94e-06	0.000147	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CRABP1—kidney cancer	4.9e-06	0.000146	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—BCHE—kidney cancer	4.69e-06	0.00014	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC5A5—kidney cancer	4.63e-06	0.000138	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ITPR2—kidney cancer	4.55e-06	0.000136	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC2A1—kidney cancer	4.47e-06	0.000133	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTGS2—kidney cancer	4.44e-06	0.000132	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.34e-06	0.000129	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.19e-06	0.000125	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTT1—kidney cancer	4.15e-06	0.000124	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ACHE—kidney cancer	4.15e-06	0.000124	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTGS2—kidney cancer	4.07e-06	0.000121	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—POMC—kidney cancer	4.02e-06	0.00012	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SCARB1—kidney cancer	3.93e-06	0.000117	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS1—kidney cancer	3.89e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTEN—kidney cancer	3.87e-06	0.000115	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PSMD7—kidney cancer	3.81e-06	0.000114	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—POMC—kidney cancer	3.8e-06	0.000113	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.78e-06	0.000113	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTP1—kidney cancer	3.73e-06	0.000111	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—BCHE—kidney cancer	3.62e-06	0.000108	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.57e-06	0.000107	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTEN—kidney cancer	3.55e-06	0.000106	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCB1—kidney cancer	3.53e-06	0.000105	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.45e-06	0.000103	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—GSTM1—kidney cancer	3.43e-06	0.000102	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.25e-06	9.69e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTGS2—kidney cancer	3.21e-06	9.56e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTGS2—kidney cancer	3.03e-06	9.04e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTP1—kidney cancer	2.88e-06	8.58e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTEN—kidney cancer	2.8e-06	8.34e-05	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.73e-06	8.14e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCB1—kidney cancer	2.72e-06	8.12e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.67e-06	7.96e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—GSTM1—kidney cancer	2.64e-06	7.89e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTEN—kidney cancer	2.64e-06	7.88e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.51e-06	7.48e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—kidney cancer	2.5e-06	7.46e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—POMC—kidney cancer	2.42e-06	7.22e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.97e-06	5.88e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTGS2—kidney cancer	1.93e-06	5.76e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—POMC—kidney cancer	1.87e-06	5.57e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.86e-06	5.56e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTEN—kidney cancer	1.68e-06	5.02e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTGS2—kidney cancer	1.49e-06	4.45e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTEN—kidney cancer	1.3e-06	3.88e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.19e-06	3.54e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.17e-07	2.74e-05	CbGpPWpGaD
